New diagnosis of polycystic ovary syndrome

  title={New diagnosis of polycystic ovary syndrome},
  author={Isabel McLuskie and Aisha Newth},
  journal={British Medical Journal},
#### What you need to know A 27 year old woman with a recent diagnosis of polycystic ovary syndrome comes to see you. She wants to know more about the condition and the consequences for her health (box 1). #### Box 1: Background facts Polycystic ovary syndrome affects 6%-7% of women.1 Women may experience The relation between polycystic ovary syndrome and obesity is poorly understood. Polycystic ovary syndrome is not caused by, and does not cause, obesity. However, obesity is associated… 

Prevalence of Clinical and Paraclinical Symptoms and Findings in Patients with Polycystic Ovary Syndrome in Ultrasound and Their Fertility Outcomes

Polycystic ovarian syndrome is a multifactorial disorder which has a wide range of clinical and biochemical complications and symptoms.

Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review

This review provides a comprehensive overview of the current knowledge about the efficacy of natural molecule supplementation in the management of PCOS.

The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?

Increased β-trophin is closely associated with increased ES in patients with PCOS, which may be the useful indicators for the management of PCOS.

Serum Leptin Concentration is Correlated to Insulin Resistance in Polycystic Ovary Syndrome (PCOS) Patients

There was a significant correlation between serum leptin levels and HOMA-IR values in PCOS patients, and this correlation was found to be significant regardless of patient's BMI, therefore is considered to have a direct effect on insulin resistance in PCos.

Correlation between Estradiol Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome

  • M. Alirezaei
  • Medicine, Biology
    Sarem Journal of Reproductive Medicine
  • 2019
The role of sex hormones in the development of insulin resistance and the role of insulin sensitivity by sex hormones is investigated in this study.

Circulating Microparticles as Indicators of Cardiometabolic Risk in PCOS.

Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice

Although there is a biological plausibility linking the status of vitamin D and insulin resistance supported by basic and clinical research findings, well-designed randomized clinical trials as well as basic research are necessary to know the molecular pathways involved in this association.

Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis

A systematic review and meta-analysis of longitudinal studies linking polycystic ovary syndrome and cardiometabolic disease quantifies this risk, which is important for clinicians to inform patients and to take into account in the cardiovascular risk assessment of women with PCOS.



Impact of Obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines

  • Medicine
    Human fertility
  • 2007
Women should be provided with assistance to lose weight, including psychological support, dietary advice, exercise classes and where appropriate, weight reducing agents or bariatric surgery, to restore fertility and improve metabolic markers.